ACI
IART icon

AMP Capital Investors’s Integra LifeSciences IART Stock Holding History

AMP Capital Investors’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,200
Closed -$219K – 563
2021
Q3 		$219K Buy
+3,200
New +$226K ﹤0.01% 1068

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

AMP Capital Investors's IART Position: Q4 2021 in Review

AMP Capital Investors sold out of Integra LifeSciences (IART) in Q4 2021, closing a stake of 3,200 shares — an estimated $219K sold.

AMP Capital Investors first reported a position in IART in Q3 2021 and held it in 1 quarter. The position peaked at $219K in Q3 2021. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

  • AMP Capital Investors reported no remaining Integra LifeSciences position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 3,200 Integra LifeSciences shares in Q4 2021, an estimated $219K.
  • AMP Capital Investors first reported a position in Integra LifeSciences in Q3 2021 and held it in 1 quarter.
  • AMP Capital Investors's Integra LifeSciences position peaked at $219K in Q3 2021.
  • 277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.